imatinib mesylate has been researched along with Ptosis, Eyelid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jandial, A; Kopp, CR; Malhotra, P; Mishra, K; Sandal, R | 1 |
| Berenguer-Potenciano, M; Camacho-Salas, A; Nunez-Enamorado, N; Perez-Alonso, V; Simon-De Las Heras, R; Villora-Morcillo, N | 1 |
2 other study(ies) available for imatinib mesylate and Ptosis, Eyelid
| Article | Year |
|---|---|
Myasthenia gravis unmasked by imatinib.
Topics: Adult; Blepharoptosis; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Myasthenia Gravis; Neostigmine; Prednisolone; Pyridostigmine Bromide | 2019 |
[Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blepharoptosis; Cranial Nerve Diseases; Daunorubicin; Diagnosis, Differential; Esotropia; Female; Guillain-Barre Syndrome; Humans; Imatinib Mesylate; Infant; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyridostigmine Bromide; Pyridoxine; Quadriplegia; Vincristine | 2015 |